More articles from Emerging Treatments and Technologies

You have access
Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
Gary E. Meininger, Russell Scott, Maria Alba, Yue Shentu, Edmund Luo, Himal Amin, Michael J. Davies, Keith D. Kaufman, Barry J. Goldstein

Diabetes Care Dec 2011, 34 (12) 2560-2566; DOI: 10.2337/dc11-1200
You have access
Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide
Michael J. Haller, Clive H. Wasserfall, Maigan A. Hulme, Miriam Cintron, Todd M. Brusko, Kieran M. McGrail, Theresa M. Sumrall, John R. Wingard, Douglas W. Theriaque, Jonathan J. Shuster, Mark A. Atkinson, Desmond A. Schatz

Diabetes Care Dec 2011, 34 (12) 2567-2569; DOI: 10.2337/dc11-1406
You have access
Diabetes Antibody Standardization Program
Michael Schlosser, Patricia W. Mueller, Peter Achenbach, Vito Lampasona, Polly J. Bingley, Participating Laboratories

Diabetes Care Nov 2011, 34 (11) 2410-2412; DOI: 10.2337/dc11-1161
You have access
Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study
Richard M. Bergenstal, William V. Tamborlane, Andrew Ahmann, John B. Buse, George Dailey, Stephen N. Davis, Carol Joyce, Bruce A. Perkins, John B. Welsh, Steven M. Willi, Michael A. Wood, for the STAR 3 Study Group

Diabetes Care Nov 2011, 34 (11) 2403-2405; DOI: 10.2337/dc11-1248
You have access
Long-Term Metabolic and Immunological Follow-Up of Nonimmunosuppressed Patients With Type 1 Diabetes Treated With Microencapsulated Islet Allografts
Giuseppe Basta, Pia Montanucci, Giovanni Luca, Carlo Boselli, Giuseppe Noya, Barbara Barbaro, Meirigeng Qi, Katie P. Kinzer, José Oberholzer, Riccardo Calafiore

Diabetes Care Nov 2011, 34 (11) 2406-2409; DOI: 10.2337/dc11-0731
You have access
Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
Nick Giannoukakis, Brett Phillips, David Finegold, Jo Harnaha, Massimo Trucco

Diabetes Care Sep 2011, 34 (9) 2026-2032; DOI: 10.2337/dc11-0472
Open Access
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Pratik Choudhary, John Shin, Yongyin Wang, Mark L. Evans, Peter J. Hammond, David Kerr, James A.M. Shaw, John C. Pickup, Stephanie A. Amiel

Diabetes Care Sep 2011, 34 (9) 2023-2025; DOI: 10.2337/dc10-2411
You have access
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin
Michael A. Nauck, Stefano Del Prato, Juris J. Meier, Santiago Durán-García, Katja Rohwedder, Martina Elze, Shamik J. Parikh

Diabetes Care Sep 2011, 34 (9) 2015-2022; DOI: 10.2337/dc11-0606
You have access
Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
Bertrand Cariou, Yassine Zaïr, Bart Staels, Eric Bruckert

Diabetes Care Sep 2011, 34 (9) 2008-2014; DOI: 10.2337/dc11-0093
You have access
Cluster Analysis of Self-Monitoring Blood Glucose Assessments in Clinical Islet Cell Transplantation for Type 1 Diabetes
Morihito Takita, Shinichi Matsumoto, Hirofumi Noguchi, Masayuki Shimoda, Daisuke Chujo, Takeshi Itoh, Koji Sugimoto, Jeffery A. SoRelle, Nicholas Onaca, Bashoo Naziruddin, Marlon F. Levy

Diabetes Care Aug 2011, 34 (8) 1799-1803; DOI: 10.2337/dc10-1938

Main menu

User menu

Search

More articles from Emerging Treatments and Technologies

Pages

Navigate

More Information

Other ADA Resources